Log In
BCIQ
Print this Print this
 

RO6836191

  Manage Alerts
Collapse Summary General Information
Company Roche
DescriptionNot disclosed
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationAtherosclerosis
Indication DetailsTreat atherosclerosis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today